Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of Multiple Doses of Henagliflozin in Healthy Subjects
NCT02361138Phase 1Completed
- Sponsor
- Hengrui
- Start
- Dec 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of henagliflozin in type 2 diabetes mellitus (T2DM) (7 arms), sponsored by Hengrui. Primary endpoints: Area under the curve at Day 13, Maximum concentration at Day 13 and 7 more. Started Dec 2013; status: completed.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02361138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02361138.